Matthew Grennan

Matthew Grennan is an economist who studies competition and innovation, using empirical and theoretical models from industrial organization. His research and teaching examine how incentives and information affect how products are developed, adopted, priced, and ultimately deliver value for stakeholders and society. He has particularly extensive experience in life sciences, medical technology, and health care. His work has informed business strategy and policy debates regarding price transparency, relationships between physicians and industry, regulation of new products, and antitrust. He has also developed multiple courses on data analytics and the application of frontier machine learning and causal inference methods in business and public policy.

Grennan is a Research Associate at the National Bureau of Economic Research and an Editor at the Journal of Political Economy Microeconomics. He is currently Acting Associate Professor of Economics at Emory University, on leave from the Haas School of the University of California, Berkeley where he held the Robinson Chancellor’s Chair and was Faculty Co-Director of the Robinson Life Science, Business, and Entrepreneurship Program. He was previously on the faculty at Wharton and Toronto and received his PhD from NYU Stern in Economics and Business Strategy.

Professor Grennan’s research has been published in the top general interest journals in economics, management, and policy, including the American Economic Review, Management Science, and Health Affairs; and funded through leading institutions such as the National Science Foundation and National Institute for Health Care Management.

Professor Grennan teaches at the undergraduate, MS, MBA, PhD, and Executive Education levels in the areas of industrial organization, cost-benefit analysis, entrepreneurship, data analytics, and technology strategy and marketing. He has received teaching awards from Berkeley, Wharton, Toronto, and Poets & Quants.

Professor Grennan has advised and presented before government bodies on issues such as estimating market power in innovative industries, modeling pricing with bargaining, efficiencies in hospital mergers, and the robustness of the medical supply chain. He has also advised numerous start-ups and provided consulting services to companies such as Medtronic and Google. He has served as an expert witness in litigation matters, including being deposed and testifying at trial, in matters involving antitrust, class action damages, intellectual property, and merger contract disputes for clients such as Abbott, CVS, Department of Justice, Johnson & Johnson, and Walmart.